About Malachite Innovations, Inc. (MLCT) — Dividend Analysis 2026
Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.
Is MLCT a good dividend investment in 2026?
MLCT offers a 1025.64% forward yield with a 50% payout ratio. Strand Safety Score: 0/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
MLCT DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your MLCT portfolio grows to $326587179.56M vs $1.04M without reinvestment. This is the compound interest effect in action.
MLCT dividend growth history & forecast
MLCT has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 1025.64%.
Company generates negative FCF ($-2M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
0 / 30 pts
0/30
Company is reporting net losses — dividend sustainability is in question
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
0
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 MLCT Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MLCT.
Gross yield
1025.64%
Tax rate
15.00%
After-tax yield
871.79%
Real yield (−CPI)
868.99%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
1025.64%
1022.84%
$102,564 / yr
🇺🇸 US Taxable (15%) ✓
15%
871.79%
868.99%
$87,179 / yr
🇺🇸 US Taxable (20%)
20%
820.51%
817.71%
$82,051 / yr
🇬🇧 UK ISA
0%
1025.64%
1022.84%
$102,564 / yr
🇬🇧 UK Taxable
8.75%
935.90%
933.10%
$93,590 / yr
🇨🇦 TFSA
0%
1025.64%
1022.84%
$102,564 / yr
🇨🇦 CA Taxable
25%
769.23%
766.43%
$76,923 / yr
🇦🇺 Super (pension)
15%
871.79%
868.99%
$87,179 / yr
🇦🇺 AU Taxable
30%
717.95%
715.15%
$71,795 / yr
🇩🇪 DE Taxable
26.375%
755.13%
752.33%
$75,513 / yr
🇫🇷 FR Taxable
30%
717.95%
715.15%
$71,795 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MLCT Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your MLCT investment of $0.20/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$75118348.17M
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$75118348.17M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in MLCT for:
Shares needed
14,118
Capital required
$2,753
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MLCT Dividend Payment Schedule
MLCT pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 MLCT vs Healthcare Benchmarks
How MLCT compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+1022.84% vs sectorBetter
MLCT
1025.64%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
MLCT
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
MLCT
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MLCT sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MLCT Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
-1.78
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
2/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MLCT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →